Optimize Sertraline Dosing First, Then Consider Switching or Augmentation
Your patient is on a subtherapeutic dose of sertraline (59 mg) - increase it to the therapeutic range of 100-200 mg daily before making other changes. The current regimen uses trazodone primarily for sleep rather than depression treatment, so the sertraline bears the primary antidepressant burden and must be optimized 1.
Immediate Action: Dose Optimization
- Increase sertraline to at least 100 mg daily, with potential titration up to 200 mg daily as tolerated 2
- Reassess response after 6-8 weeks at the therapeutic dose 1
- The 59 mg dose is below the typical therapeutic range and insufficient for treating major depression
Critical Context for Anorexia Nervosa
Depression treatment in underweight AN patients has limited evidence and poor response rates 3, 4. The neurobiological changes from starvation fundamentally alter antidepressant efficacy:
- SSRIs show minimal benefit during acute AN with low weight 3
- Antidepressants work better after weight restoration 5
- If your patient remains significantly underweight, prioritize nutritional rehabilitation alongside medication adjustments 6, 3
However, emerging evidence suggests that in patients with comorbid depression (even moderate severity), antidepressants may provide benefit beyond just treating depression - they can improve the entire anorexic syndrome 5, 7.
If Inadequate Response After 6-8 Weeks
Modify treatment per ACP guidelines 1:
Option 1: Switch to Different SSRI or Antidepressant
- All second-generation antidepressants show equivalent efficacy for depression 1
- Consider switching based on side effect profile:
Option 2: Augmentation Strategy
- Limited evidence exists for preferring one augmentation strategy over another 1, 8
- Bupropion augmentation may reduce depression severity more than buspirone 8
Special Considerations for AN Population
Monitor closely for suicidality - SSRIs increase risk of nonfatal suicide attempts, particularly in the first 1-2 months 1, 9. This risk is compounded by the high mortality rate in AN itself 3.
Weight restoration remains paramount:
- Set individualized weekly weight gain goals 6
- Coordinate with multidisciplinary team including nutritional expertise 6
- Consider that fluoxetine specifically shows benefit for relapse prevention in weight-restored AN patients with persistent depression 5
Practical Algorithm
- Week 0: Increase sertraline to 100 mg daily
- Week 2: Assess tolerability, monitor for suicidality, check weight
- Week 4: If tolerated but insufficient response, increase to 150-200 mg daily
- Week 6-8: Reassess depression and eating disorder symptoms
- If inadequate response: Switch to mirtazapine (especially if poor appetite/sleep) or augment with bupropion (if low energy/apathy)
Common pitfall: Abandoning sertraline before reaching therapeutic doses. Many clinicians underdose SSRIs in eating disorder patients due to concerns about side effects, but this guarantees treatment failure 2, 9.
The trazodone can continue at 100 mg for sleep, as it provides sedation but limited antidepressant efficacy at this dose 1.